- Home
- WELL
WELL
Welltower Inc.
as 03-28-2025 4:00pm EST
Welltower owns a diversified healthcare portfolio of 2,271 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
| Founded: | 1970 | Country: | United States |
| Employees: | N/A | City: | TOLEDO |
| Market Cap: | 94.3B | IPO Year: | N/A |
| Target Price: | $152.23 | AVG Volume (30 days): | 3.6M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.57 | EPS Growth: | 139.07 |
| 52 Week Low/High: | $87.87 - $158.55 | Next Earning Date: | 04-28-2025 |
| Revenue: | $7,991,118,000 | Revenue Growth: | 21.58% |
| Revenue Growth (this year): | 21.1% | Revenue Growth (next year): | 11.55% |
Latest Welltower Inc. News
WELL Breaking Stock News: Dive into WELL Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
WELL: What does Argus have to say about WELL?
MT Newswires
5 days ago
Deutsche Bank Adjusts Welltower Price Target to $165 From $150
Zacks
10 days ago
Zacks Industry Outlook Highlights Welltower, SBA Communications and SL Green Realty
Zacks
11 days ago
Bet on These 3 Equity REIT Stocks Despite Industry Challenges
MT Newswires
11 days ago
Raymond James Adjusts Price Target on Welltower to $171 From $155, Maintains Strong Buy Rating
Zacks
16 days ago
Welltower (WELL) Up 0.6% Since Last Earnings Report: Can It Continue?
Zacks
17 days ago
Welltower Stock Gains 14.5% in 3 Months: Will it Continue to Rise?
MT Newswires
17 days ago
Citigroup Adjusts Price Target on Welltower to $175 From $155, Keeps Buy Rating
Compare WELL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WELL Welltower Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.